SimCardioTest will demonstrate the benefit of in-silico trials, testing three use cases in cardiology.
Our health data can significantly contribute to better disease prevention, early diagnosis in a safe and secure way. SimCardioTest, led by Inria, gathers ten international partners including VPHi, and is funded by the European Commission. The aim of SimCardioTest is to demonstrate the feasibility, efficacy and benefits of in-silico trials for disease. SimCardioTest is developing […]